Clinical Trial Update: A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study evaluating how BI 1015550 is absorbed into the bloodstream in people with and without hepatic impairment, with results posted a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency

Drugs mentioned

• BI-1015550 (BI-1015550)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2025-11-28